RBC Life Sciences Inc
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products. RBC Life Sciences, Inc. is headquartered in Irving, Texas.
Market Cap & Net Worth: RBC Life Sciences Inc (RBCL)
RBC Life Sciences Inc (PINK:RBCL) has a market capitalization of $221.30 ($221.30) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51401 globally and #16107 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RBC Life Sciences Inc's stock price $0.00 by its total outstanding shares 2213010 (2.21 Million).
RBC Life Sciences Inc Market Cap History: 2015 to 2025
RBC Life Sciences Inc's market capitalization history from 2015 to 2025. Data shows change from $553.25K to $221.30 (-60.26% CAGR).
RBC Life Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RBC Life Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
RBC Life Sciences Inc's market cap is 0.03 times its annual revenue
0.11x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $553.25K | $24.37 Million | -$741.84K | 0.02x | N/A |
| 2016 | $663.90K | $25.77 Million | -$756.28K | 0.03x | N/A |
Competitor Companies of RBCL by Market Capitalization
Companies near RBC Life Sciences Inc in the global market cap rankings as of March 19, 2026.
Key companies related to RBC Life Sciences Inc by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #35 globally with a market cap of $351.41 Billion USD.
- Unilever PLC (PINK:UNLYF): Ranked #141 globally with a market cap of $131.81 Billion USD.
- UNILEVER PLC LS -,035 (XETRA:UNV0): Ranked #147 globally with a market cap of $126.11 Billion USD ( €122.86 Billion EUR).
- L'Oréal S.A (PINK:LRLCF): Ranked #215 globally with a market cap of $94.58 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #35 | Procter & Gamble Company | NYSE:PG | $351.41 Billion | $151.48 |
| #141 | Unilever PLC | PINK:UNLYF | $131.81 Billion | $60.96 |
| #147 | UNILEVER PLC LS -,035 | XETRA:UNV0 | $126.11 Billion | €56.81 |
| #215 | L'Oréal S.A | PINK:LRLCF | $94.58 Billion | $368.10 |
RBC Life Sciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, RBC Life Sciences Inc's market cap moved from $553.25K to $ 221.30, with a yearly change of -60.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $221.30 | 0.00% |
| 2024 | $221.30 | 0.00% |
| 2023 | $221.30 | -99.23% |
| 2022 | $28.77K | +3150.00% |
| 2021 | $885.20 | -99.80% |
| 2020 | $442.60K | +244.83% |
| 2019 | $128.35K | -72.91% |
| 2018 | $473.81K | -28.63% |
| 2017 | $663.90K | 0.00% |
| 2016 | $663.90K | +20.00% |
| 2015 | $553.25K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of RBC Life Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $221.30 USD |
| MoneyControl | $221.30 USD |
| MarketWatch | $221.30 USD |
| marketcap.company | $221.30 USD |
| Reuters | $221.30 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.